The content on this site is intended for healthcare professionals only
Prostate & urology
Lung & pleura
Colorectal & gastro
Melanoma & skin
Head & neck
Ovary & gynaecology
Brain & nervous system
cancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.
Please login or register. Then you can use this button to confirm you are part of this project.
Register for free
Already have an account?
Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers
Novel DNA aptamer for CYP24A1 inhibition ID’d, possible target for anticancer therapy
Age-related lung changes provide pathway for metastatic growth of dormant melanoma cancer cells
Ultrasound-guided microbubbles boost immunotherapy efficacy
The paired perils of breast cancer and diabetes
ECOG-ACRIN research highlights at ASCO 2022
ASCO 2022: Targeting p53 pathway shows promise for patients with Merkel cell carcinoma
ASCO 2022: Novel immunotherapy combination improved survival in patients with metastatic melanoma
ASCO 2022: Desmoplastic melanoma responds to PD-1 blockade immunotherapy
Patient voices a good predictor of cancer treatment outcomes